Drugs / Allantoic Split Inactivated Seasonal flu Vaccine
last change Dec 2016 re-read 2 minutes ago

Allantoic Split Inactivated Seasonal flu Vaccine

Vaccine

Developed for
influenza

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03016143 Comparator Oct → Nov 2016 influenza Research Institute for Biological Safety Problems Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Allantoic Split Inactivated Seasonal flu Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT03016143
Modality Vaccine “Allantoic split inactivated seasonal influenza vaccineNCT03016143